Clinical Trials (GI Cancer)

Search

Query

Comprehensive Diabetes Care at UAB Comprehensive Diabetes Care at UAB
Ovalle_Video_Promo.jpg

Patients at the Multidisciplinary Gastrointestinal Oncology Center have access to many clinical trials conducted by the University of Alabama Comprehensive Cancer Center.

The following clinical trials may be available to Multidisciplinary Gastrointestinal Oncology Center patients.

This list changes frequently as new studies open and old ones close.

Disease	Protocol	Description
Colon Cancer	ECOG E5202	Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab
Liver Cancer	UAB 0708	A Pharmacokinetic Study of BMS-582664 in Subjects with Advanced Solid Malignancies and Normal Hepatic Function, and/or Hepatocellular Carcinoma with Impaired Hepatic Function
Pancreatic Cancer	UAB 0641	A Phase I Trial of Gemcitabine (Gemzar^{^TM}) Plus ABI-007 (Abraxane^{^TM}) in Patients with Advanced Metastatic Pancreatic
Metastatic Gastric Cancer	UAB 0717	A Phase 2 Study of XL880 Administered Orally to Patients with poorly differentiated diffuse metastatic gastric cancer
Pancreatic Cancer	UAB 0601	A Phase 2 Double-Blind, Placebo-Controlled, Multi-Center Adjuvant Trial of the Efficacy, Immunogenicity, and Safety of GI-4000, an Inactivated Recombinant Saccharomyces cerevisiae Expressing Mutant Ras Protein Combined with a Gemcitabine Regimen Versus a Gemcitabine Regimen with Placebo, in Patients with Post-Resection R0/R1 Pancreatic Cancer with Tumor Sequence Confirmation of Ras Mutations